CC0000: The color(s) blue, black, orange and tan is/are claimed as a feature of the mark.
D10000: "CLOSTRIDIAL COLLAGENASE FOR INJECTION"
DM0000: The mark consists of a rectangle with the word mark "XIAFLEX" in blue on a white background in the center with an orange design completing the "A" and "F" with the wording "CLOSTRIDIAL COLLAGENASE FOR INJECTION" in black below "XIAFLEX" and below all the wording appears a larger horizontal wave design having, from top to bottom, bands of orange, blue and tan colors.
GS0051: Pharmaceutical preparations, namely, collagenase enzyme used to treat fibroproliferative disease conditions, namely, Dupuytren's contracture, Peyronie's disease and frozen shoulder syndrome also known as adhesive capsulitis
Case File Event Statements
10/19/2011 - 13 years ago
22 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLYType:ASCK
1/11/2010 - 14 years ago
21 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
1/11/2010 - 14 years ago
20 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
6/9/2009 - 15 years ago
19 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
3/17/2009 - 15 years ago
18 - PUBLISHED FOR OPPOSITIONType:PUBO
2/25/2009 - 15 years ago
17 - NOTICE OF PUBLICATIONType:NPUB
2/10/2009 - 15 years ago
16 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
2/10/2009 - 15 years ago
15 - ASSIGNED TO LIEType:ALIE
1/30/2009 - 15 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/30/2009 - 15 years ago
13 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
1/30/2009 - 15 years ago
12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
1/30/2009 - 15 years ago
11 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
1/30/2009 - 15 years ago
10 - EXAMINERS AMENDMENT -WRITTENType:CNEA
1/8/2009 - 15 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
1/8/2009 - 15 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
1/8/2009 - 15 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
12/5/2008 - 16 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN